ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1325

Musculoskeletal Manifestations in Ebola Survivors

Duane Pearson1, Lisa Davis2, John Frankhauser3 and Liron Caplan4, 1Division of Rheumatology, University of Colorado, Aurora, CO, 2Div of Rheumatology, Denver Health, Denver, CO, 3Serving In Mission, Monrovia, Liberia, 4Div of Rheumatology, Denver VA and University of Colorado School of Medicine, Aurora, CO

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Enthesitis, Musculoskeletal and infection

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Infection-related Rheumatic Disease - Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Musculoskeletal complaints are common among survivors of Ebola Virus Disease (EVD) and can have clinical impacts beyond two years post-convalescence. The frequency of these manifestations has been described in several post-convalescent populations, but with very little detail. This study helps detail arthritis manifestations in EVD survivors.

Methods: EVD survivors were evaluated at an established survivors’ clinic between 6/29/2015 & 7/2/2015. A trained rheumatologist formally evaluated self-selected survivors, and data were recorded on a standardized form. Summary statistics were then performed.

Results: Forty-six Ebola survivors presented to the survivors’ clinic and were evaluated. The mean age was 37.8 years, ranging from 14 to 68 years of age at the time of evaluation. The survivors who presented to the clinic were 54% female and 46% male. Of those whose musculoskeletal complaints could be related to the Ebola infection (i.e., the infection preceded the symptoms), n=42, the mean number of days between being released from the Ebola Treatment Unit (ETU) and development of arthritis symptoms was 46.6 days, SD of 81.5 days. The most striking feature of the Ebola survivors’ musculoskeletal symptoms is the high prevalence of enthesitis. Of those examined, 43% had enthesitis in at least one site identified for formal spondyloarthritis examinations after a mean of 202 days of symptoms. Only 7% had one or more swollen joints. Sacroiliac joint tenderness was not a common feature, with only 5% with a positive exam. Twenty-six percent espoused past or present uveitis.

Conclusion: Musculoskeletal complaints are reportedly common among EVD survivors. In a self-selected survivor population, the musculoskeletal complaints are most notable for a predominance of enthesitis with an absence of signs of inflammatory arthritis and sacroiliitis.


Disclosure: D. Pearson, None; L. Davis, None; J. Frankhauser, None; L. Caplan, None.

To cite this abstract in AMA style:

Pearson D, Davis L, Frankhauser J, Caplan L. Musculoskeletal Manifestations in Ebola Survivors [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/musculoskeletal-manifestations-in-ebola-survivors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-manifestations-in-ebola-survivors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology